Another blow to Apple smartwatches over patent infringement

There have been many accusations that one company is copying the products and functions of another. These statements are probably true to some extent, as everyone wants to offer their customers the best final product with all possible functions. In particular, the company Apple stands out here, which has been accused and also convicted several times for the unauthorized use of registered patents, as it fights with all its might to acquire as many customers as possible for its products, and this despite their own lack of innovation.

At the end of December last year, the American International Trade Commission (ITC) took action against Apple due to the unauthorized use of registered technology. Apple is supposed to infringed two of Masimo's total of five blood oxygen saturation (SPO2) patents. As of December 24, Apple has been banned from selling the Apple Watch Series 9 and Ultra 2 smart watches in the United States of America. The aforementioned sales ban applied to both online and physical stores.

Even before the end of last year, Apple managed to obtain a temporary injunction to end the ban on the import and sale of smart watches in the USA. The court ordered that Apple can continue selling the aforementioned watches until the company receives an answer as to whether the proposed changes are enough to comply with the patent technology. But since this did not happen, Apple was dealt another blow.

Due to the failed agreements with the company Masimo, the Apple company namreÄ US owners of the Apple Watch 9 and Ultra 2 have started to remove the ability to measure blood oxygen saturation (SPO2). This company Apple is starting by updating the software code for its latest smartwatches. The new watches, which will be sold in online and physical stores, will still be available without the option of measuring blood oxygen saturation (SPO2). At the moment, it is not yet known how the new restriction will affect the sale of Apple smart wristwatches on the American market. Many are convinced that the decline in sales will be negligible.